BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$6.32B |
| 2 |
Microsoft
MSFT
|
+$5.03B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$3.87B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$3.27B |
| 5 |
Amazon
AMZN
|
+$2.75B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kellanova
K
|
+$2.54B |
| 2 |
Mr. Cooper
COOP
|
+$1.79B |
| 3 |
DuPont de Nemours
DD
|
+$1.69B |
| 4 |
Sandisk
SNDK
|
+$1.29B |
| 5 |
Mastercard
MA
|
+$1.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.74% |
| 2 | Financials | 12.64% |
| 3 | Healthcare | 10.22% |
| 4 | Consumer Discretionary | 9.81% |
| 5 | Communication Services | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Charles Schwab
SCHW
$167B
| $13.4B | 0.23% |
134,167,833
+1,887,079
| +1% | +$179M |
2013 Q2
50 quarters
|
|
77
Newmont
NEM
$124B
| $13B | 0.22% |
129,969,380
+7,642,703
| +6% | +$691M |
2013 Q2
50 quarters
|
|
78
Boston Scientific
BSX
$61.9B
| $13B | 0.22% |
135,987,245
-9,188,624
| -6% | -$901M |
2013 Q2
50 quarters
|
|
79
Prologis
PLD
$123B
| $12.7B | 0.21% |
99,448,504
+3,115,939
| +3% | +$388M |
2013 Q2
50 quarters
|
|
80
Uber
UBER
$146B
| $12.6B | 0.21% |
154,770,602
+3,786,210
| +3% | +$341M |
2019 Q2
26 quarters
|
|
81
Arista Networks
ANET
$273B
| $12.5B | 0.21% |
95,448,955
+6,153,123
| +7% | +$847M |
2014 Q3
45 quarters
|
|
82
Capital One
COF
$122B
| $12.4B | 0.21% |
51,005,251
+1,057,706
| +2% | +$235M |
2013 Q2
50 quarters
|
|
83
Pfizer
PFE
$161B
| $12.3B | 0.21% |
493,062,528
-4,372,016
| -0.9% | -$110M |
2013 Q2
50 quarters
|
|
84
Danaher
DHR
$155B
| $11.9B | 0.2% |
52,037,352
-262,686
| -0.5% | -$57.7M |
2013 Q2
50 quarters
|
|
85
Progressive
PGR
$126B
| $11.9B | 0.2% |
52,094,073
+3,391,410
| +7% | +$766M |
2013 Q2
50 quarters
|
|
86
Analog Devices
ADI
$197B
| $11.7B | 0.2% |
43,255,569
+365,746
| +0.9% | +$91.9M |
2013 Q2
50 quarters
|
|
87
Boeing
BA
$150B
| $11.7B | 0.2% |
53,968,134
+2,683,054
| +5% | +$552M |
2013 Q2
50 quarters
|
|
88
Medtronic
MDT
$113B
| $11.6B | 0.2% |
120,537,878
+969,072
| +0.8% | +$94.1M |
2013 Q2
50 quarters
|
|
89
Union Pacific
UNP
$165B
| $11.4B | 0.19% |
49,196,593
+594,066
| +1% | +$136M |
2013 Q2
50 quarters
|
|
90
Palo Alto Networks
PANW
$343B
| $11B | 0.19% |
59,562,981
+4,123,075
| +7% | +$832M |
2013 Q2
50 quarters
|
|
91
Blackrock
BLK
$168B
| $10.8B | 0.18% |
10,093,082
+18,233
| +0.2% | +$19.9M |
2013 Q2
50 quarters
|
|
92
Vertex Pharmaceuticals
VRTX
$129B
| $10.8B | 0.18% |
23,751,989
+1,498,942
| +7% | +$646M |
2013 Q2
50 quarters
|
|
93
iShares Core S&P Total US Stock Market ETF
ITOT
$97.9B
| $10.5B | 0.18% |
70,712,218
+1,047,193
| +2% | +$155M |
2015 Q1
43 quarters
|
|
94
Honeywell
HON
$65.8B
| $10.3B | 0.17% |
52,606,486
+592,310
| +1% | +$116M |
2013 Q2
50 quarters
|
|
95
CrowdStrike
CRWD
$282B
| $9.92B | 0.17% |
84,620,376
+1,916,104
| +2% | +$244M |
2019 Q2
26 quarters
|
|
96
Howmet Aerospace
HWM
$89.8B
| $9.69B | 0.16% |
47,241,701
-917,989
| -2% | -$183M |
2016 Q4
36 quarters
|
|
97
Stryker
SYK
$106B
| $9.65B | 0.16% |
27,449,327
+720,608
| +3% | +$263M |
2013 Q2
50 quarters
|
|
98
CVS Health
CVS
$110B
| $9.6B | 0.16% |
120,994,474
+1,158,330
| +1% | +$91.3M |
2013 Q2
50 quarters
|
|
99
Lowe's Companies
LOW
$104B
| $9.56B | 0.16% |
39,647,486
+474,776
| +1% | +$114M |
2013 Q2
50 quarters
|
|
100
Bristol-Myers Squibb
BMY
$121B
| $9.54B | 0.16% |
176,825,406
+1,310,241
| +0.7% | +$63M |
2013 Q2
50 quarters
|
|
Similar funds
BlackRock's Q4 2025 Portfolio in Review
As of Q4 2025, BlackRock held 5,676 positions worth $5.92T, up 3.6% from $5.71T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
BlackRock's Q4 2025 filing shows 223 new, 3,158 increased, 1,507 reduced and 143 closed positions. Its largest new stake was Qnity Electronics Inc: 15,929,395 shares worth $1.3B. The largest sale was Kellanova, an estimated $2.54B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q4 2025 buy was Qnity Electronics Inc: 15,929,395 shares worth $1.3B.
- BlackRock added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $6.32B increase.
- BlackRock's biggest Q4 2025 reduction was DuPont de Nemours, cutting an estimated $1.69B.
- BlackRock fully exited Kellanova in Q4 2025, selling an estimated $2.54B.
- BlackRock's ten largest holdings make up 30% of its $5.92T portfolio in Q4 2025.
- BlackRock opened 223 new positions and closed 143 in Q4 2025.
- BlackRock's portfolio value rose 3.6% quarter-over-quarter to $5.92T.
Based on BlackRock's 13F filing for Q4 2025, filed 12 Feb 2026.